Ferring automates invoicing; Teva, APP sign supply deal;

> Ferring Pharmaceuticals is rolling out document management software to speed up invoicing and procurement. Article

> APP Pharmaceuticals has signed a commercialization, manufacturing and supply pact with Teva Pharmaceutical for Gemcitabine HCI for Injection. Item

> Contract manufacturer Lonza says it improved capacity utilization in biological manufacturing in the second half of 2010. Article

> China's United Laboratories International Holdings has received production approval for three recombinant human insulin products. Article

> New Zealand police have arrested a suspect in an Internet counterfeit-drug marketing gang. Story

> Active CC Boxes has opened a cold chain depot near Frankfurt, Germany to handle its Kodiak reusable shipping containers. Story

> Prolong Pharmaceuticals has signed a long-term lease on a manufacturing facility in South Plainfield, NJ. Prolong release

> Takeda Pharmaceutical has completed construction of an API manufacturing facility for investigational antibodies within its Hikari Plant. Article

Suggested Articles

The FDA is bracing for drug and medical supply shortages in the U.S. as the COVID-19 outbreak from China continues to spread globally.

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.